Similar Articles

Browse Main Topics:

Business
Computers & Electronics
Education & Reference
Entertainment & Leisure
Family & Home
Finance & Investment
Health
Internet
Pets & Animals
Science & Technology
Society, Politics & Culture
Sports & Recreation

Similar Articles

American Family Physician July 15, 2002 Dana E. King	Acute Management of Atrial Fibrillation: Part II. Prevention of Thromboembolic Complications Family physicians should be familiar with the acute management of atrial fibrillation and the initiation of chronic therapy for this common arrhythmia. Part II of this two-part article focuses on the prevention of thromboembolic complications using anticoagulation.
American Family Physician December 15, 2003	How to Prevent a Stroke What is a stroke?... What increases my risk of having a stroke?... What can I do to lower my risk of having a stroke?... Can medicine help lower my risk of stroke?... etc.
American Family Physician July 15, 2002 Dana E. King	Acute Management of Atrial Fibrillation: Part I. Rate and Rhythm Control Atrial fibrillation is the arrhythmia most commonly encountered in family practice. Initial treatment is directed at controlling the ventricular rate. Medical or electrical cardioversion to restore sinus rhythm is the next step in patients who remain in atrial fibrillation.
American Family Physician December 1, 2004	Heart Failure-What Do I Need to Know About It? A patient bulletin discussing what heart failure is, its most common causes, treatment options, ways to prevent the disease, etc.
The Motley Fool August 30, 2011 Brian Orelli	Pfizer and Bristol-Myers Glide Through For Pfizer and Bristol-Myers Squibb's new atrial fibrillation treatment, Eliquis, the devil seems to have left the building.
AskMen.com	Living With A Heart Condition Actor and comedian Kevin Nealon is proof that older men can live (and thrive) with a heart condition
The Motley Fool July 2, 2009 Robert Steyer	At Last, a Heartening Drug Approval French drug giant sanofi-aventis gets FDA approval for a drug to treat an erratic heartbeat.
The Motley Fool November 16, 2010 Brian Orelli	Well, That Just Stinks Glaxo's Lovaza doesn't fix heart rhythm problems.
American Family Physician June 15, 2002 A. Kesh Hebbar	Management of Common Arrhythmias: Part I. Supraventricular Arrhythmias Family physicians frequently encounter patients with symptoms that could be related to cardiac arrhythmias, most commonly atrial fibrillation or supraventricular tachycardias.
American Family Physician June 15, 2005 Mark H. Ebell	Decision-Making Tool for Treating Patients with Nonvalvular Atrial Fibrillation What is the risk of stroke in a patient with nonvalvular atrial fibrillation, and should that patient be given warfarin (Coumadin) or aspirin?
Nursing March 2012 Susan Simmons	Recognizing and preventing Acute stroke in women In women, stroke is the third leading cause of death, after heart disease and cancer, and the major cause of disability.
AskMen.com Joshua Levine	Preventing A Heart Attack: Part I The warnings signs of a stroke, types of strokes, prevention, and rehabilitation.
The Motley Fool November 30, 2011 Brian Orelli	Drugmakers Bleeding Out That's not what blood thinners are supposed to do.
Nurse Practitioner September 2011 Wells & Kalman	Women & Heart Disease: Symptoms and Treatment Guidelines Coronary heart disease is the leading cause of death for women. Nurse practitioners need to educate women about their risk and follow practice guidelines.
Nutrition Action Healthletter September 2001	Brain Attack: What you need to know about stroke...
The Motley Fool August 28, 2007 Andrew R. Vaino	Cardiome's Hearty Outlook If the FDA renders a favorable decision on an anti-fibrillation drug, Cardiome's heart may well skip a beat. As with any investment based on FDA approval, of course, there is substantial risk involved.
The Motley Fool September 8, 2011 Arlene Weintraub	Bristol-Pfizer Team on Alert as FDA Reviews Stroke-Prevention Drug From Rivals J&J and Bayer Who will come out ahead?
Nursing September 2009 AnneMarie Palatnik	Too fast, too slow, too ugly: Dysrhythmias that every nurse should recognize Learn how to recognize an abnormal cardiac rhythm and intervene appropriately.
American Family Physician April 1, 2004 Nina Solenski	Transient Ischemic Attacks: Part II. Treatment Risk factors for stroke should be evaluated in patients who have had a transient ischemic attack.
American Family Physician April 15, 2003 Adan & Crown	Diagnosis and Treatment of Sick Sinus Syndrome Sick sinus syndrome comprises a variety of conditions involving sinus node dysfunction and commonly affects elderly persons. While the syndrome can have many causes, it usually is idiopathic.
Salon.com January 24, 2000 David Weir	Bradley's lonely heart club His condition, according to one who has it, is nothing to get heartsick about.
American Family Physician December 15, 2003 Ezekowitz et al.	Stroke: Strategies for Primary Prevention Stroke is a leading cause of morbidity and mortality. Every year, approximately 500,000 Americans have a first stroke, and approximately 20 percent die within 30 days. This article summarizes strategies that have been shown to be effective in stroke prevention.
American Family Physician February 15, 2005 Allan V. Abbott	Diagnostic Approach to Palpitations An increased or abnormal awareness of the heartbeat, palpitations are a common symptom in patients presenting to family physicians. Palpitations can be symptomatic of life-threatening cardiac arrhythmias.
The Motley Fool November 22, 2010 Brian Orelli	Pfizer's Mixed Bag Pfizer had a mixed bag of clinical trial results at the end of last week. And probably the company would have rather seen the results flip-flopped.
Nurse Practitioner February 2012 Wood & Gordon	Preventing CVD in women: The NP's role This article focuses on the new American Heart Association guidelines for preventing cardiovascular disease in women and the nurse practitioner's role in implementing them.
IEEE Spectrum November 2008 Kroll et al.	Idiot-proofing the Defibrillator How a device that shocks a failing heart back to life became one of the greatest engineering success stories in medicine
The Motley Fool November 27, 2007 Brian Lawler	Cardiome Makes Them Wait Cardiome Pharma announces a delay in the release of data on an oral version of its lead heart drug. Investors, take note.
The Motley Fool September 9, 2011 Brian Orelli	Firing Squad, It Was Not J&J and Bayer get through their advisory panel with minimal problems.
The Motley Fool September 7, 2011 Brian Orelli	J&J and Bayer Head in Front of the Firing Squad An expanded indication for Xarelto seems unlikely.
The Motley Fool April 6, 2011 Brian Orelli	$1 Billion in Drug Sales Bleeds Out Don't feel too bad for Bayer and J&J though.
The Motley Fool July 5, 2011 Brian Orelli	Drug Approved, But No Fireworks Yet The second FDA approval for Bayer and Johnson & Johnson's Xarelto is more important.
Managed Care November 2007 Thomas Morrow	Cryoablation for Atrial Flutter Requires No Anesthesia Compared with radiofrequency ablation, this technique has some advantages and it should be acceptable to managed care plans.
American Family Physician June 1, 2004 Gutierrez & Blanchard	Diastolic Heart Failure: Challenges of Diagnosis and Treatment The outcomes of ongoing clinical trials may provide much-needed information about diastolic heart failure to move from intuitive treatment to therapy based on evidence that matters: decreased morbidity and mortality and improved quality of life.
The Motley Fool June 11, 2010 Brian Orelli	Pfizer and Bristol Coagulate Against Clots Let's see how apixaban does against warfarin before we break out the "blockbuster" stamp.
IEEE Spectrum December 2007 Kroll & Tchou	How a Taser Works The stun gun shocks without killing, but how safe is it? Two experts take a look.
Pharmaceutical Executive December 1, 2010 Walter Armstrong	Acute Coronary Syndrome A new class of anticoagulants is competing to dethrone difficult-to-manage warfarin, long the sole option in the prevention of stroke and other bleeding complications in the 2.5 million US patients with atrial fibrillation.
The Motley Fool November 14, 2007 Brian Lawler	Busy Times Ahead for Cardiome Keep an eye on Canadian drug developer Cardiome Pharma over the next three months; its entire pipeline of drugs will be receiving regulatory scrutiny during this time.
The Motley Fool December 12, 2007 Brian Lawler	No Shock for Cardiome An FDA advisory panel gives the nod to Cardiome's heart drug. Investors, take note.
The Motley Fool June 23, 2011 Brian Orelli	In Addition, Our Drug Actually Rocks Pfizer and Bristol get good data on Eliquis.
The Motley Fool April 20, 2005 Stephen D. Simpson	St. Jude's Healthy Heartbeat Medical device maker St. Jude continues to be boosted by ICD market share gains, and new businesses are coming on line, as well.